Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer.

Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P.

J Urol. 2014 Mar;191(3):597-602. doi: 10.1016/j.juro.2013.08.081.

2.

Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.

Ehdaie B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, Coleman JA, Dalbagni G.

BJU Int. 2013 Apr;111(4):589-95. doi: 10.1111/j.1464-410X.2012.11260.x.

3.
4.

Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.

Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML.

J Urol. 2002 Aug;168(2):454-9.

PMID:
12131287
5.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
6.

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V; Members of the CORONA project and the SATURN project..

Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030.

PMID:
22748912
7.

Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.

Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK.

J Urol. 2016 Feb;195(2):270-6. doi: 10.1016/j.juro.2015.08.072.

PMID:
26292038
8.

Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.

May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S; CORONA and SATURN projects.; Young Academic Urologists Renal Cancer Group..

J Urol. 2013 Aug;190(2):458-63. doi: 10.1016/j.juro.2013.02.035.

PMID:
23434943
9.

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.

Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Jul;168(1):56-60.

PMID:
12050492
10.

Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.

Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration..

Eur Urol. 2013 Jun;63(6):1082-90. doi: 10.1016/j.eururo.2012.06.029.

11.

Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.

Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P.

J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048.

PMID:
19286201
12.

Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.

Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK.

Eur J Surg Oncol. 2016 Mar;42(3):419-25. doi: 10.1016/j.ejso.2015.09.023.

PMID:
26520403
13.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project.; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation..

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x.

14.

External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.

Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.

J Urol. 2008 Oct;180(4):1290-5; discussion 1295-6. doi: 10.1016/j.juro.2008.06.014.

PMID:
18707704
15.

Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma.

Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH.

J Urol. 2014 Dec;192(6):1620-7. doi: 10.1016/j.juro.2014.06.014.

PMID:
24931804
16.

Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.

Parker A, Lohse C, Cheville J, Leibovich B, Igel T, Blute M.

Int J Urol. 2008 Apr;15(4):304-8. doi: 10.1111/j.1442-2042.2008.01994.x.

17.

The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.

Capitanio U, Matloob R, Suardi N, Abdollah F, Castiglione F, Di Trapani D, Russo A, Briganti A, Carenzi C, Salonia A, Montorsi F, Rigatti P, Bertini R.

Urologia. 2012 Apr-Jun;79(2):109-15. doi: 10.5301/RU.2012.9255.

18.

Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.

Ito N, Kojima S, Teramukai S, Mikami Y, Ogawa O, Kamba T.

Int J Clin Oncol. 2015 Dec;20(6):1161-70. doi: 10.1007/s10147-015-0840-5.

PMID:
25981949
19.

Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes.

Patel NH, Attwood KM, Hanzly M, Creighton TT, Mehedint DC, Schwaab T, Kauffman EC.

J Urol. 2015 Sep;194(3):640-6. doi: 10.1016/j.juro.2015.03.125.

PMID:
25896558
20.

Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.

Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM.

J Urol. 2012 Aug;188(2):391-7. doi: 10.1016/j.juro.2012.04.006.

Items per page

Supplemental Content

Support Center